David Andrew
9Patents
6h-index
10Co-inventors
52Inventor score
Filing activity: Jan 15, 1999 → Apr 19, 2005
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6488930B1 | Anti-CCR4 antibodies and methods of use therefor | Human Necessities | 44 | Expired |
| US7138117B1 | Anti-CCR4 antibodies and methods of use therefor | Human Necessities | 28 | Expired |
| US6329159A | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6936248B1 | Methods of inhibiting GPR-9-6 function | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6689570B2 | Methods of identifying agents which bind GPR-9-6 | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6884574B2 | Methods of identifying agents which inhibit GPR-9-6 | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7381412B2 | Anti-TECK antibodies and methods of use therefor | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7485301B2 | Methods of treating inflammatory disease using antibodies which bind GPR-9-6 | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7566536B2 | WNT-regulated cytokine-like polypeptide and nucleic acids encoding same | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.